PACIFIC SMILES GROUP LIMITED (PSQ)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

PSQ - PACIFIC SMILES GROUP LIMITED
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.59
Index: ALL-ORDS
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.055
05 Dec |
OPEN $1.06 |
HIGH $1.06 |
16,345 LOW $1.05 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
ACL . AHX . ALC . BMT . CAJ . DOC . EBO . HLA . HLS . M7T . MDR . MPL . MVF . NHF . RHC . SHL . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 1.5 | 6.5 | xxx |
DPS (cps) | xxx | 2.6 | N/A | xxx |
EPS Growth | xxx | N/A | 100.0% | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | 16.2 | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | 172.4% | 0.0% | xxx |
Last ex-div: 21/09 - ex-div 2.27c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 1.5 |
DPS All | xxx | xxx | xxx | xxx | xxx | 2.6 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 165.3 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 38.4 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 40.9 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 1.46 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 4.03 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 1.66 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 1.28 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 4.03 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 3.61 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 29.2 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 14 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 79 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 93 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 13 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 19 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 3.53 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 11.1 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 6.70 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 132 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 27 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
PSQ STOCK CHART

FNArena News on PSQ
1 |
Australian Broker Call *Extra* Edition – Aug 30, 2023Aug 30 2023 - Daily Market Reports |
2 |
FNArena Corporate Results Monitor – 25-08-2023Aug 25 2023 - Australia |
3 |
Australian Broker Call *Extra* Edition – Jul 17, 2023Jul 17 2023 - Daily Market Reports |
4 |
Australian Broker Call *Extra* Edition – May 02, 2023May 02 2023 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Mar 06, 2023Mar 06 2023 - Daily Market Reports |
Latest Healthcare services News
1 |
Treasure Chest: Ramsay Health CareOct 26 2023 - Treasure Chest |
2 |
Timing Seems Right For Alcidion GroupJun 21 2023 - Small Caps |
3 |
No Enthusiasm To Combine ACL & HealiusMar 21 2023 - Australia |
4 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
5 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
6 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
7 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
8 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |
9 |
Ramsay Stakes Future on Mental HealthDec 20 2021 - Australia |
10 |
Ramsay Health Care: Finally A Break-OutNov 09 2021 - Technicals |